Showing posts with label Vaccination. Show all posts
Showing posts with label Vaccination. Show all posts

Wednesday, 15 April 2026

Monkey Pox outbreak in Democratic Republic of Congo officially declared to have ended.

An outbreak of Monkey Pox in the Democratic Republic of Congo which has been raging since 2023 has officially been declared to have ended by the Ministry of Public Health. During the course of the epidemic, 161 000 people are thought to have been infected with the disease in the Democratic Republic of Congo, with 37 000 cases confirmed by laboratory testing. A total of 2286 deaths have been attributed to the disease within the country, although only 127 of these were confirmed by laboratory testing. At the height of the epidemic the disease spilled over into several neighbouring, and internationally connected, countries, causing the World Heath Organization to declare a global emergency.

A patient with Monkey Pox waiting at the Kamituga General Hospital in South Kivu Province, Democratic Republic of Congo, in September 2004. Moses Sawasawa/AP.

Monkeypox (or Mpox) is caused by a double-stranded DNA virus of the genus Orthopoxvirus, which is the same genus as the Viruses which cause Smallpox and Cow Pox. It causes a Chickenpox-like disease, with a distinctive rash with large blisters or sores on all parts of the body, as well as a fever, headaches, muscle and back aches, joint pain, chills, exhaustion, and swollen glands. Most patients recover within a few weeks, however it can cause more dangerous secondary symptoms, including pneumonia, sepsis, encephalitis, and blindness. Older and younger patients are particularly at risk, as are patients who have weakened immune systems or are pregnant. The disease typically has a case fatality ratio of about 1%.

Monkeypox is a zoonotic disease, with a wild reserve of the Virus found in several species of Primates and Rodents. Outbreaks usually start with an Animal-to-Human infection, although Humans at the blistering stage of the disease are capable of spreading it to other Humans. The Virus was first detected in Crab-eating Macaques, Macaca fascicularis, in a laboratory in Denmark in 1958, an outbreak which gave the disease its name (it is now thought to be more prevalent in Rodents than Primates). The first known Human infection with Monkeypox was reported from the Democratic Republic of Congo in 1970.

Monkeypox Virus size and structure in comparison to HIV, SARS-COV-2 and Poliovirus. Membranes and membrane-bound proteins are in purple, capsids are in dark blue, and genomes and nucleoid-associated proteins are in turquoise. PDB-101.

There are two main clades of Monkeypox, Clade I, which is predominantly found in Central Africa, and Clade II, which is predominantly found in West Africa. However, in May 2022 a cluster of cases was found in London, England, which is thought to have been brought to the country by a patient from Nigeria. These infections were caused by a new strain, which was apparently transmitted from Human-to-Human more readily than previously encountered variants, and was given the identifier Clade IIb (because it was a new clade derived from Clade II, which subsequently became referred to as Clade IIa. Notably, the spread of this strain has been linked to sexual activity. Clade IIb subsequently spread to 121 countries over the next two years, infecting more than 99 500 people and causing over 200 deaths.

In September 2023, another new and apparently more virulent variant, later named Clade Ib, was identified in the mining town of Kamituga in South Kivu Province, Democratic Republic of Congo. This spread from Human-to-Human more readily than previously known forms of the disease, and had a case fatality ratio of 3-4%, making it much deadlier than previously encountered variants. Unlike Clade IIb, Clade Ib appeared to spread largely among children, with 70% of reported cases and 85% of reported deaths being under the age of 15, although it has been suggested that this is in part because the disease has spread through several large refugee camps, where large numbers of children are also suffering from malnutrition, as well as other infectious diseases such as Cholera and Measles. 

Clade Ib has subsequently been reported in 25 countries, although in most cases this has been single patients who developed symptoms of the disease after returning from travel to Central Africa. However, in neighbouring countries such as Burundi, Rwanda, and the Central African Republic, as well as Indonesia and the Philippines, the clade has begun to spread locally, leading to public health campaigns to contain it.

Fortunately, because Monkeypox is closely related to Smallpox, vaccines against that disease have been shown to be effective against its spread. Because the last recorded case of Smallpox was in 1977, and the disease was declared officially globally eradicated in 1980, few countries maintain a stock of the vaccine, and active vaccination programs against Smallpox have not been carried out for decades. However, the technology to produce these vaccines still exists, and manufacturers in the United States, Spain, and Denmark have been distributing the vaccines since 2024.

See also...









Wednesday, 8 April 2026

More than 100 dead in outbreak of Measles in Bangladesh.

More than 100 people have died of suspected Measles in an outbreak of the disease in Bangladesh. Cases started appearing in mid-March 2026, since when more than 7500 suspected cases have been reported, with more than 4600 people hospitalised, almost all of whom are young children, with about one third of those affected being under nine months old. Over 900 cases have been laboratory-confirmed, including 16 of those who lost their lives.

A patient being treated for Measles at the Dhaka Medical College in Bangladesh. Drik Picture Library/Getty Images.

Measles is a human disease caused by a Virus in the Paramyxovirus family. The Virus infects the respiratory tract, then spreads throughout the body. It can lead to major epidemics with significant morbidity and mortality, especially among vulnerable people. Among young and malnourished children, pregnant women, and immunocompromised individuals, including those with HIV, cancer or treated with immunosuppressives, Measles can cause serious complications, including severe diarrhoea, blindness, encephalitis, pneumonia, and death.

Thin-section transmission electron micrograph revealing the ultrastructural appearance of a single Viron, of the Measles Virus. The measles Virus is a Paramyxovirus, of the genus Morbillivirus. It is 100-200 nm in diameter, with a core of single-stranded RNA, and is closely related to the Rinderpest and Canine Distemper Viruses. Two membrane envelope proteins are important in pathogenesis. They are the F (fusion) protein, which is responsible for fusion of virus and host cell membranes, viral penetration, and hemolysis, and the H (hemagglutinin) protein, which is responsible for adsorption of virus to cells. Centers for Disease Control and Prevention/Wikimedia Commons.

Transmission is primarily person-to-person by airborne respiratory droplets that disperse rapidly when an infected person coughs or sneezes. Transmission can also occur through direct contact with infected secretions. Transmission from asymptomatic exposed immune persons has not been demonstrated. The Virus remains contagious in the air or on contaminated surfaces for up to two hours. A patient is infectious from four days before the start of the rash to four days after its appearance. There is no specific antiviral treatment for Measles, but most people recover within 2-3 weeks.

An effective and safe vaccine is available for prevention and control. The Measles-containing-vaccine first-dose is given at the age of nine months, while the Measles-containing-vaccine second dose is given at the age of 15 months. A 95% population coverage of Measles-containing-vaccine first-dose and Measles-containing-vaccine second dose is required to stop measles circulation.

In areas with low vaccination coverage, epidemics typically occur every two to three years and usually last between two and three months. However, their duration varies according to population size, crowding, and the population’s immunity status.

The Measles outbreak in Bangladesh this year is thought to have been linked to the recent political instability in the country, as well as the Covid-19 pandemic. Bangladesh typically runs a major Measles vaccination campaign every four years. However, the 2020 campaign is thought to have been disrupted by the diverting of staff and resources to deal with the impacts of the Covid-19 pandemic, and the 2024 campaign was cancelled amid the political turmoil which led to the removal of the country's president, Sheikh Hasina, and the installation of an interim government under the economist Muhammad Yunus, which made repairing the country's economic and political systems a priority.

Following elections in February 2026, a new government was sworn in, led by Tarique Rahman of the Bangladesh National Party. This new government has launched a major new Measles vaccination campaign in response to the epidemic, beginning with 30 identified hotspots in 20 of the country's 64 districts, targeting 1.2 million children between the ages of six months and five years who have not received the vaccination. 

See also...





Friday, 20 March 2026

Two dead in Meningitis outbreak in Kent, southern England.

Two people have died in an outbreak of Meningitis in the city of Canterbury, in Kent, southern England, this week, according to the UK Health Security Agency. Both of those who have died have been described as having been teenage students studying at the University of Kent. A further eighteen cases of the disease have been confirmed, sixteen of whom live in or close to Canterbury, with one patient each in London and Paris, both of whom are known to have visited Canterbury immediately before becoming unwell. A further eleven possible cases are under investigation. 

The location of the University of Kent. Google Maps.

Meningitis is a serious infection of the meninges, the membranes covering the brain and spinal cord. Several different Bacteria can cause Meningitis, however, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis (sometimes spelled Neisseria meningitis) are the most common, and are transmitted from person to person through droplets of respiratory or throat secretions from infected people.

The average incubation period for Meningococcal Meningitis is 4 days, but can range between 2 and 10 days. The most common symptoms of Meningitis are a stiff neck, high fever, sensitivity to light, confusion, headaches and vomiting. Even with early diagnosis and adequate treatment, 5% to 10% of patients die, typically within 24 to 48 hours after the onset of symptoms. Bacterial Meningitis may result in brain damage, hearing loss or a learning disability in 10% to 20% of survivors. A less common, but even more severe (and often fatal), form of Meningococcal Disease is Meningococcal Septicaemia, which is characterised by a haemorrhagic rash and rapid circulatory collapse.

The Canterbury outbreak has been linked to the B serotype of Neisseria meningitidis, a form of Betaproteobacterium. A serotype is a distinct population within a species of Bacteria or Virus which presents different antigen proteins on the surface of its cells, and therefore requires the body to develop a different antibody response. A total of 12 serotypes of Neisseria meningitides have been identified, six of which (A, B, C, W, X and Y) can cause Meningococcal Meningitis epidemics.

Two serotypes 1a and 1b with antigens 2a and 2b on surface. Corresponding antibodys 3a and 3b with the possibility to bind to the antigens. Anna Bauer/Wikimedia Commons.

In the UK, a vaccine for Neisseria meningitidis serotypes A, C, W, & Y is typically offered to school pupils aged 14-15, while a vaccine for serotype B, which is particularly associated with outbreaks in infants, is offered to babies. However, this latter vaccination was only introduced in 2015, and therefore most people over the age of 15 in the UK are not vaccinated against this strain. The charity Meningitis Now, which campaigns on issues relating to the disease in the UK, as well as offering advise to those affected by or concerned about Meningitis, has been campaigning for a roll-out of the serotype B vaccine to older groups. 

As a response to the current outbreak, the University of Kent has arranged for a vaccination program for students to be set up on its campus, where antibiotics, which can help to fight the disease, are also available. Advice for staff and students at the university can be found here. Other people who are concerned that they may have been exposed should contact their GP (a GP, or General Practitioner, is a family doctor in the UK), or the National Health Service's NHS111 help service.

Students at the University of Kent in Canterbury queuing to get Meningitis B vaccine. PA Media.

See also...





Sunday, 17 November 2024

Global number of Measles cases rose by 20% in 2023.

The number of Measles cases recorded worldwide rose by 20% in 2023 (compared to 2022), with 10.3 million cases recorded globally, according so a joint press release issued by the World Health Organization and the U.S. Centers for Disease Control and Prevention. The main driver of this rise in cases is thought to be inadequate immunization coverage.

Two doses of Measles vaccine is sufficient to protect against infection with the disease, but 17% of children who should have received their first dose of the vaccine in 2023 are thought not to have done so (more than 22 million children), while 26% of children who should have received a second dose in 2023 did not do so. A vaccine coverage rate of 95% or higher for both vaccine doses is thought to be needed to prevent Measles spreading within a population.

Fifty seven countries are thought to have suffered Measles outbreaks due to gaps in vaccination coverage, a 60% rise on the 36 countries which suffered such outbreaks in 2022. The World Health Organization's African, Eastern Mediterranean, European, South-East Asia and Western Pacific regions were affected, with over half of outbreaks occurring in the African Region. Only the Americas Region was not affected by a Measles outbreak in 2023.

A doctor examines a girl with measles at the Republican Infectious Diseases Clinical Hospital, Bishkek city, Kyrgyzstan. Danil Usmanov/World Health Organization.

'Measles vaccine has saved more lives than any other vaccine in the past 50 years,' according to Tedros Adhanom Ghebreyesus, the Director General of the World Health Organization. 'To save even more lives and stop this deadly virus from harming the most vulnerable, we must invest in immunization for every person, no matter where they live.'

Measles is a human disease caused by a Virus in the Paramyxovirus family. The Virus infects the respiratory tract, then spreads throughout the body. It can lead to major epidemics with significant morbidity and mortality, especially among vulnerable people. Among young and malnourished children, pregnant women, and immunocompromised individuals, including those with HIV, cancer or treated with immunosuppressives.

Thin-section transmission electron micrograph revealing the ultrastructural appearance of a single Viron, of the Measles Virus. The measles Virus is a Paramyxovirus, of the genus Morbillivirus. It is 100-200 nm in diameter, with a core of single-stranded RNA, and is closely related to the Rinderpest and Canine Distemper Viruses. Two membrane envelope proteins are important in pathogenesis. They are the F (fusion) protein, which is responsible for fusion of virus and host cell membranes, viral penetration, and hemolysis, and the H (hemagglutinin) protein, which is responsible for adsorption of virus to cells. Centers for Disease Control and Prevention/Wikimedia Commons.

It is estimated that 107 500 people died of Measles in 2023, most of them children below the age of five. This is an eight 8% drop in fatalities compared to 2022. The reason for this lower fatality rate in 2023, despite a higher infection rate, is thought to be that more cases of Measles were reported in 2023 in countries with generally better healthcare and childhood nutrition rates, where infected children are less likely to die. However, this is not all good news, as even where Measles is not fatal, it can cause a number of severe health problems, including blindness, pneumonia, and encephalitis (swelling of the brain, often leading to brain damage).

Measles is one of twenty life-threatening diseases which it was hoped could be eliminated through vaccination campaigns by 2030 under the remit of the Immunization Agenda 2030 program. In the first week of November 2024, Brazil was declared to be Measles-free, meaning that the disease had been eliminated in the Americas Region, and at least one nation in each of the other regions, with the exception of Africa, also having Measles-free status. However, the decline in vaccine-uptake, and the subsequent rise in Measles cases around the world, means that this project is now threatened.

The African and Eastern Mediterranean regions are thought to be in particular need of urgent and targeted interventions to ensure vaccine availability and uptake, particularly in conflict-affected and other vulnerable settings. Greater surveillance for cases is also needed in all regions, in order to facilitate prompt responses to outbreaks when they occur.

See also...

Friday, 26 January 2024

The epidemiology of the 2020 Ebola outbreak in Équateur Province, Democratic Republic of the Congo.

On 1 June 2020 medical authorities in Ã‰quateur Province, Democratic Republic of the Congo, reported an outbreak of Ebolavirus Disease in Mbandaka, the capital of Équateur Province. This was the eleventh reported outbreak of an Ebola-type disease in the Democratic Republic of the Congo, and was close to the location of a previous outbreak in the Bikoro health zone of Équateur Province, which occurred in 2018. The Democratic Republic of the Congo suffered fifteen outbreaks of Ebola-type diseases between 1 September 1976 and 22 August 2022, with the 2020 Équateur Province outbreak being the eleventh of these. The majority of these were caused by the Ebolavirus, and occurred in the north of the country, although one, in Haut-Uélé Province in 2012, was caused by the Bundibugyo Virus.

Ebolavirus has not been found in Bats in the Democratic Republic of the Congo, but the closely related Marburg Virus has, and Bats with antibodies to Ebolavirus have been found in Nord Kivu Province and Équateur provinces, as well as in the neighbouring Republic of Congo. Outbreaks of Ebola have been associated with the handling of Chimpanzees and Gorillas in the Republic of Congo and Gabon, and Ape populations have been known suffer dramatic declines at the same time as local Human populations have suffered outbreaks of Ebola-type diseases. Furthermore, as with other Filoviruses, Ebolavirus can persist in the system of survivors after they have apparently recovered, and cause new infections via sexual transmission or other exchange of bodily fluids. Before it became possible to identify Ebolaviruses by rapid genetic sequencing, it was impossible to tell whether outbreaks of the disease were caused by new infections from zoonotic sources (i.e. Animals) or transmission from apparently heathy survivors.

In a paper published in the journal The Lancet Microbe on 23 January 2024, a team of scientists led by Eddy Kinganda-Lusamaki of the Pathogen Genomics Laboratory at the Institut National de Recherche Biomédicale in Kinshasa, the Faculté de Médecine at the Université de Kinshasa, and the Institut de Recherche pour le Développement at the University of Montpellier, present the results of an assessment of the epidemiological and genetic properties of the 2020 Ã‰quateur Province Ebola outbreak.

The 2020 Équateur Province outbreak was the Democratic Republic of the Congo's eleventh Ebola outbreak, and started while the tenth outbreak, in North Kivu Province, was still ongoing. This led to suspicions that the two events were related, with the Équateur Province potentially being caused by an infected person travelling from North Kivu. Kinganda-Lusamaki et al. were able to demonstrate that this was not the case, with the two outbreaks being caused by different strains of Ebolavirus, and the Équateur Province outbreak having a zoonotic origin.

Ebolavirus outbreaks in the Democratic Republic of the Congo, 1976–2022. (A) The distribution of Ebolavirus disease outbreaks in the Democratic Republic of the Congo. Coloured circles identify locations of previous outbreaks and the size of circles represents the number of positive Human cases. The map shows the affected 2020 health zones (orange and purple shading) and sites of the 2018 Équateur outbreak (orange shading). The red star indicates the location of the Kinshasa diagnostic laboratory during the Équateur Province 2020 outbreak. (B) The locations and prevalence of Ebolavirus disease cases during the 2020 Ebola virus disease outbreak in the Équateur Province. The red stars indicate the location of the diagnostic and field laboratories during the Équateur Province 2020 outbreak (Mbandaka, Ingende, Itipo, Bikoro, and Bolomba). Kinganda-Lusamaki et al. (2024).

Blood samples from live patients with suspected Ebola and oral swabs from deceased patients thought to have died of Ebola were tested for signs of the Virus. Unlike in previous outbreaks, the presence of a fever was not required for patients to be included in the suspected group, since it has been demonstrated that not all people infected with Ebolavirus develop a fever.

Between 19 May and 16 September 2020, 130 probable cases of Ebola were reported in., 119 of which were confirmed by laboratory analysis. Of the 130 suspected cases, 55 died, a case fatality rate of 42%. Cases were reported in thirteen health zones, Bikoro, Bolenge, Bolomba, Bomongo, Iboko, Ingende, Lilanga Bobangi, Lolanga Mampoko, Lotumbe, Mkanza, Mbandaka, Monieka, and Wangata. The epidemic declined rapidly after August, with the last case being reported on 12 September. Thhe highest number of infections was among men in the 45 or older age bracket, while the least affected group were children aged 5-14. This is surprising, as Équateur Province has a young population, with many more children than older men. This was particularly true in the early stages of the epidemic, with no individuals of 15 or younger affected in May or June, while several children were infected between July and September. The date of the first onset of symptoms was identified for all cases. Forty seven infected persons visited more one health clinic after the onset of symptoms, with three individuals visiting four separate health clinics. The earliest identified case was a 37-year-old woman identified as a housewife, residing in the Mbandaka health zone, who had no contact with any known earlier case, but who was known to have consumed wild Bat meat, strongly suggesting a zoonitic origin for the epidemic.

Demographics of Ebolavirus Disease cases during the 2020 Équateur Province outbreak (A) Epidemiological curve of confirmed and probable Ebolavirus Disease cases over time. (B) Age distribution of confirmed and probable Ebolavirus Disease cases by gender (the black horizontal bars represent the 2020 Democratic Republic of the Congo known age and gender population distribution from the World Health Organization). (C) Temporal age distribution of individuals with Ebolavirus Disease. (D) Distribution of patients with Ebolavirus Disease who visited multiple health-care facilities after symptoms onset. Kinganda-Lusamaki et al. (2024).

Three of the people infected during the epidemic were healthcare workers, and one a traditional healer. Two of these died. Thirty seven of the infected were described as farmers, fishers, or hunters, 25 as housewives, and seven as businesspeople. Ninety four of the infected people are known to have had contact with another known case before becoming infected. Nine reported having contact with an unidentified person who they thought might be infected, 23 had no known link to another case, and four reported contact with Animals which may have passed on the infection.

Nineteen of the infected are believed to have contracted the Virus from a member of their household, twenty from another member of their community, twelve people are thought to have contracted the Virus at a funeral. Twenty seven patients reported multiple potential contact sources, in 44 cases the route of exposure was unknown.

While it was not possible to obtain specimens from all patients, Kinganda-Lusamaki et al. were able to obtain 188 specimens from 122 of the patients, from which they were able to sequence 87 viral genomes. This led to the discovery that there were in fact two separate variants of the Virus circulating during the epidemic, with 83 of the genomes belonging to the Mbandaka variant of the Virus and three belonging to the Tumba variant; a partial sequence (defined as a sequence where less than 70% of the Viruses DNA was recovered) obtained from another patient was also identified as belonging to the Tumba variant. All of the Mbandaka variant cases were calculated to have descended from a last common ancestor which probably existed in a non-Human host in January 2020, with two separate instances of the Virus jumping to Human hosts and then spreading within the community. The first known example of the Tumba variant in the 2020 outbreak was a nineteen-year-old man who visited two separate healthcare clinics before being diagnosed. This patient had no-known contact with any earlier patient, nor had he consumed bushmeat or had contact with any wild or domestic Animals. All three subsequent cases had had contact with this initial case. The previous outbreak of Ebola in Ã‰quateur Province in 2018 was also the Tumba variant of the Virus, although it was impossible to determine whether the new outbreak was due to a persistent infection from the earlier epidemic.

By using patient-generated data, Kinganda-Lusamaki et al. were able to generate a history of the 2020 Ebolavirus outbreak in Ã‰quateur Province, Democratic Republic of the Congo, which included genetic data, records of health centre visits, dates of infection, identification of the Virus, isolation of patients, and deaths. This enabled them to plot chains of infection, with nineteen chains of infection being determined before generic data was incorporated into the study, and eighteen of these subsequently being stitched together with genetic data to form the Mbandaka variant tree. Twenty of the patients had no determined route of infection, with eleven of these also subsequently added to the Mbandaka variant tree from genetic data; genetic data was not available from the remaining nine patients. Three individuals reported that believing they had contracted the Virus from contact with Animals, but were demonstrated to be part  of the Human-to-Human chain of Mbandaka variant infection. Two individuals were identified from samples taken when they visited healthcare clinics for reasons unrelated to Ebolavirus; both went on to develop symptoms of the disease.

Kinganda-Lusamaki et al. were able to develop an extensive overview of the 2020 Ebolavirus outbreak in Équateur Province, but caution that this data is still probably incomplete, with cases for which the infection routes were unknown or only probable, making it likely that there were other, unidentified cases within the community. A similar pattern was observed in the concurrent epidemic in North Kivu Province. The outbreak appeared to start with an individual who consumed Bat meat, and was of a newly identified strain of the Ebolavirus, identified as the Mbandaka variant. A minority of the cases belonged to a second strain, the Tumba variant, which caused an epidemic of the disease in 2018, and appeared to re-emerge from a survivor in 2020. The Équateur Province outbreak was found to be unrelated to the concurrent North Kivu Province epidemic, contrary to expectations. Their hope is that by utilising both social and genetic data to understand the transmission of the Virus their study will enable healthcare workers to be able to better manage future outbreaks of Ebolavirus.

Kinganda-Lusamaki et al. identified several different routes of Ebolavirus infection during the 2020 outbreak, including zoonotic transmission from Animals, person-to-person infection due to close contact with infected individuals, and the re-emergence of the Virus from a persistent infection. The ability of the Virus to re-emerge as a persistent infection from apparently healthy individuals after quite long intervals has proven to be a problem in other Ebolavirus outbreaks elsewhere in the Democratic Republic of the Congo, as well as in Guinea. This can be differentiated from fresh zoonotic infections by genetic testing (the persistent infection will be genetically close to the previous outbreak, whereas a fresh zoonotic infection is likely to have a novel genome, forming their own distinct clade of infections.

Research around the 2014 Ebolavirus outbreak in Guinea, Sierra Leone, and Liberia demonstrated the importance of educating survivors of the disease of the potential dangers of transmitting the disease after all symptoms have passed, something which Kinganda-Lusamaki et al.'s emphasise.

In the 2020 Ã‰quateur Province it took an average of six days between the onset of symptoms and patients being isolated within medical facilities (which was quite often longer than the patient lived), as a consequence, many patients visited multiple healthcare facilities, increasing the number of other people they came into contact with. Based upon this, Kinganda-Lusamaki et al. strongly recommend that in future outbreaks a system of rapid testing is introduced as quickly as possible. They note that an enhanced viral haemorrhagic fever surveillance programme has helped the country to respond rapidly to several outbreaks of different haemorrhagic diseases (including Marburg Virus Disease, Crimean-Congo haemorrhagic fever, and Rift Valley fever), resulting in the severity and duration of the outbreaks being reduced. A similar system would enable the Democratic Republic of the Congo to respond in the same way.

During the last three weeks of the 2020 Équateur Province outbreak, cases were limted to six healthcare districts, falling to two in the last two weeks. Eight of the thirteen new cases reported in the last three weeks were children under fourteen years of age, possibly suggesting that the majority of older people in the area by this time were producing antibodies to the disease, either as a result of prior exposure or vaccination. During the outbreak the rVSVΔG-ZEBOV-GP vaccine was administered to all known contacts of patients who were more than six months old, as part of a  ring vaccination strategy. Unfortunately, record keeping was imperfect, and it is unclear if the reported cases in the last few weeks had been vaccinated, or whether they had been in contact with unvaccinated people. During the North Kivu outbreak the same vaccine was found not to offer absolute protection from infection, but infected people were found to suffer fewer symptoms, recovered more quickly, and were less likely to die. Vaccinated people were found to be producing antibodies to the Virus six months after they were vaccinated. It is unclear whether natural immunity, or the immunity offered by vaccination, wanes over time for Ebolavirus

See also...